Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-06

FDA Approved: PHENYTOIN — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for phenytoin from Rising Pharma Holdings, Inc., indicating an update related to the generic antiseizure medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phenytoin (Phenytoin)

Snippet

SUPPL AP for PHENYTOIN (PHENYTOIN)